发明名称 USE OF CRTH2 ANTAGONIST COMPOUNDS IN THERAPY
摘要 Compounds of general formula (f) wherein R, R, Rand Rare independently hydrogen, halo, C-Calkyl, -O(C-Calkyl), -CON(R), -SO, -SOR, -SON(R), -N(R), -NRCOR, -COR, -COR, -SR, -OH, -NOor -CN; each Ris independently hydrogen or C-Calkyl; Rand Rare each independently hydrogen, or С–Сalkyl or together with the carbon atom to which they are attached form a C-Ccycloalkyl group; Ris hydrogen or С-Сalkyl; Ris an aromatic moiety optionally substituted with one or more substituents selected from halo, С-Calkyl, -O(С-C)alkyl, -CON(R), -SOR, -SOR, -SON(R), -N(R), -NRCOR, -COR, -COR, -SR, -OH, -NOor -CN; wherein Ris as defined above; Ris hydrogen, or C-Calkyl; provided that: Ris not phenyl substituted with -COOH; when any two of R, R, Rand Rare hydrogen, neither of the other two of R, R, Rand Ris С-Сalkyl; and their pharmaceutically acceptable salts, hydrates, solvates, complexes or prodrugs are useful in the preparation of pharmaceuticals for the treatment of allergic diseases such as asthma, allergic rhinitis and atopic dermatitis.I
申请公布号 UA86602(C2) 申请公布日期 2009.05.12
申请号 UA20060005567 申请日期 2004.10.19
申请人 OXAGEN LIMITED 发明人 MIDDLEMISS DAVID;ASHTON MARK RICHARD;BOYD EDWARD ANDREW;BROOKFIELD FREDERICK ARTHUR;PETTIPHER ERIC ROY
分类号 A61K31/404;A61K31/426;A61K31/428;A61K31/4709;A61K31/498;A61P11/02;A61P11/06;A61P19/02;C07D209/08;C07D209/10;C07D209/12;C07D401/06;C07D403/06;C07D417/06 主分类号 A61K31/404
代理机构 代理人
主权项
地址